| Êëàññ IV. Áëîêàòîðû êàëüöèåâûõ êàíàëîâ | |
| Ñåëåêòèâíûå áëîêàòîðû êàëüöèåâûõ êàíàëîâ I êëàññà | |
| VERAPAMIL | |
| ÈÇÎÏÒÈÍ ÑÐ 240 | ABBOTT GmbH & Co. KG |
| ÂÅÐÀÏÀÌÈË | SERENA PHARMA Pvt.Ltd. |
| ÂÅÐÀÏÀÌÈËÀ ÃÈÄÐÎÕËÎÐÈÄ | ÀÊÐÈÕÈÍ ÎÀÎ |
| ÂÅÐÎÃÀËÈÄ ÅÐ 240 ìã | GALENA a.s. |
| ÈÇÎÏÒÈÍ | EBEWE PHARMA GmbH.Nfg.KG |
| ÈÇÎÏÒÈÍ | ABBOTT GmbH & Co. KG |
| ÔÈÍÎÏÒÈÍ | ORION CORPORATION |
| Ñåëåêòèâíûå áëîêàòîðû êàëüöèåâûõ êàíàëîâ III êëàññà | |
| DILTIAZEM | |
| ÀËÒÈÀÇÅÌ® ÐÐ | INSTITUTO LUSOFARMACO d'ITALIA S.p.A. |
| ÄÈÀÇÅÌ | MEDOCHEMIE Ltd. |
| ÄÈËÊÀÐÄÈß® | UNIQUE PHARMACEUTICAL LABORATORIES |
| ÄÈËÒÈÀÇÅÌ | PLIVA d.d. |
| ÄÈËÒÈÀÇÅÌ ËÀÍÍÀÕÅÐ | LANNACHER HEILMITTEL Ges.m.b.H. |
| ÄÈËÒÈÀÇÅÌ-ÐÀÒÈÎÔÀÐÌ | MERCKLE GmbH |
| ÊÀÐÄÈË | ORION CORPORATION |